CACI International Inc held its Annual Meeting of Shareholders on October 15, 2026, where ten nominees were elected to the Board of Directors. Shareholders also approved executive compensation on an advisory basis and ratified the appointment of PricewaterhouseCoopers LLP as the independent accounting firm for fiscal year 2027.
Kearny Financial Corp. held its Annual Meeting of Stockholders on October 20, 2026, where shareholders elected four directors to three-year terms. Stockholders also ratified the appointment of Crowe LLP as the independent auditor for fiscal 2027 and approved the company's executive compensation in an advisory vote.
Aehr Test Systems held its Annual Meeting of shareholders on October 19, 2026, where all six director nominees were elected to the board. Shareholders also ratified the selection of BPM LLP as the independent auditor for fiscal year 2027 and approved the executive compensation plan on an advisory basis.
Tempest Therapeutics reconvened and subsequently adjourned its special meeting of stockholders to November 12, 2026, to allow more time to solicit votes for a proposal to amend its charter. The proposal seeks to replace supermajority voting requirements and permit stockholder action by written consent, which requires a 75% affirmative vote to pass.
Xterax Corporation II (formerly Karman Line Acquisition Corp.) held an extraordinary general meeting where shareholders approved a formal name change and the adoption of an amended memorandum and articles of association. Approximately 85.6% of outstanding shares were represented at the meeting, and the name change took effect immediately under Cayman Islands law.
Soluna Holdings reported the results of its 2026 Annual Meeting of Stockholders held on October 16, 2026, where shareholders elected Dan Golding to the Board of Directors. Golding, a former Google executive, has served as an advisor to the company since 2023 and brings over 30 years of data center and digital infrastructure experience to the board.
Soluna Holdings held its Annual Meeting of Stockholders on October 16, 2026, where shareholders approved an amendment to increase the number of authorized shares of common stock from 375 million to 1 billion. Stockholders also elected three Class III directors, ratified the company's auditors, and approved executive compensation on an advisory basis.
iBio, Inc. held its 2026 Annual Meeting of Stockholders where shareholders approved an amendment to the 2023 Omnibus Incentive Plan to modify its 'evergreen' share increase provision through 2033. Stockholders also approved an increase in the number of authorized shares of common stock from 275 million to 500 million and re-elected two Class III directors to the Board.
Empery Digital Inc. held its annual meeting of stockholders on October 14, 2026, where shareholders elected nine directors and ratified the appointment of MaloneBailey, LLP as independent auditors. Notably, shareholders rejected the adoption of the 2025 Equity Incentive Plan, and a legal challenge was subsequently filed by ATG Capital Opportunities Fund LP regarding the board composition.
Taylor Devices, Inc. held its 2026 Annual Meeting of Shareholders on October 16, 2026. Shareholders elected Timothy J. Sopko as a Class 2 director, ratified Lumsden & McCormick, LLP as the independent auditor for fiscal year 2027, and approved executive compensation on an advisory basis.
Starry Sea Acquisition Corp provided an update on its Extraordinary General Meeting, which was previously postponed to October 19, 2026. The company reported that following the redemption deadline on October 15, 2026, a total of 3,895,270 public shares remain tendered for redemption after some holders withdrew their requests.
NRx Pharmaceuticals has scheduled its 2026 Annual Meeting of Stockholders for December 17, 2026, to be held in a virtual-only format. The company established October 28, 2026, as the record date and set October 25, 2026, as the new deadline for stockholder proposals and director nominations. These deadlines were revised because the meeting date is more than 30 days from the anniversary of the previous year's annual meeting.
Adial Pharmaceuticals has further adjourned its 2026 Annual Meeting of Stockholders with respect to Proposals 3, 4, 5, and 6 until October 26, 2026. The delay is intended to provide additional time to obtain Nasdaq's conditional approval of an Initial Listing Application related to those specific proposals.
Credo Technology Group Holding Shareholder Meeting
Credo Technology Group Holding Ltd held its 2026 Annual General Meeting on October 12, 2026, where shareholders elected three Class II directors: Sylvia Acevedo, Fariba Danesh, and Pantas Sutardja. Shareholders also approved executive compensation on an advisory basis and ratified Ernst & Young LLP as the independent auditor for the fiscal year ending May 1, 2027.
Acurx Pharmaceuticals held its Annual Meeting of Stockholders on October 16, 2026, where shareholders elected David P. Luci and Jack H. Dean as Class II directors for three-year terms. Additionally, stockholders ratified the appointment of CohnReznick LLP as the company's independent registered public accounting firm for the fiscal year ending December 31, 2026.
Polar Power, Inc. held its 2026 Annual Meeting of Stockholders on October 14, 2026, where shareholders elected six directors and ratified Weinberg & Company, P.A. as the independent auditor. Shareholders also approved a potential reverse stock split at a ratio between 1-for-3 and 1-for-20 and authorized the potential issuance of shares exceeding 19.99% of outstanding stock for future financing transactions.
Rekor Systems held its 2026 Annual Meeting of Stockholders on October 16, 2026, after multiple adjournments to achieve a quorum. Shareholders elected six directors to serve until 2027, ratified CBIZ CPAs P.C. as the independent auditor for fiscal year 2026, and approved executive compensation on an advisory basis.
Procter & Gamble reported the results of its 2026 Annual Meeting of Shareholders held on October 13, 2026. Shareholders elected 12 directors to one-year terms, ratified Deloitte & Touche LLP as the independent auditor, and approved executive compensation in an advisory 'Say on Pay' vote.
The Bank of New York Mellon Corporation announced that Vikram Malhotra, who was previously elected to the Board of Directors effective October 1, 2026, has been appointed to the Board's Risk Committee and Finance Committee. This filing serves as an amendment to a previous 8-K to finalize his committee assignments.
Paychex, Inc. held its 2026 Annual Meeting of Stockholders on October 15, 2026, where shareholders elected ten directors and approved executive compensation on an advisory basis. Shareholders also ratified PricewaterhouseCoopers LLP as the independent auditor for fiscal 2027, while a stockholder proposal regarding the right to call a special meeting was not approved.
Champions Oncology held its 2026 Annual Meeting of Stockholders where shareholders elected seven directors to serve one-year terms and ratified EisnerAmper LLP as the independent accounting firm for fiscal 2027. Stockholders also approved the 2026 Equity Incentive Plan and voted in favor of holding future executive compensation advisory votes on an annual basis.
Koss Corporation held its Annual Meeting of Stockholders on October 14, 2026, where shareholders elected five directors to the board. Stockholders also approved executive compensation on an advisory basis and ratified Wipfli LLP as the independent accounting firm for the fiscal year ending June 30, 2027.
Capitol Federal Financial, Inc. has scheduled its annual meeting of stockholders for Tuesday, January 26, 2027. The company established December 4, 2026, as the voting record date for stockholders entitled to participate in the meeting.
Oaktree Acquisition Corp. III Life Sciences Shareholder Meeting
Oaktree Acquisition Corp. III Life Sciences has postponed its extraordinary general meeting from October 16, 2026, to October 23, 2026. The meeting was called to vote on a proposal to extend the deadline for the company to complete an initial business combination. The postponement is intended to allow more time for the solicitation of shareholder proxies.
Belpointe PREP, LLC held its annual meeting of unitholders on October 12, 2026, where unitholders elected Martin Lacoff and Ronald Young, Jr. as Class II directors. Unitholders also ratified the appointment of CohnReznick LLP as the independent auditor and approved a proposal for the potential issuance of Class A units in excess of 19.99% of outstanding units at a price below the NYSE American minimum price.
Co-Diagnostics, Inc. reconvened its 2026 Annual Meeting of Stockholders on October 14, 2026, but was unable to transact business because a quorum was not present. The company determined not to adjourn the meeting again and intends to seek stockholder approval for the proposals at a future special meeting.
IB Acquisition Corp. has scheduled its 2026 Annual Meeting of Stockholders for December 16, 2026, with a record date of October 28, 2026. The meeting is intended to help the company regain compliance with Nasdaq Listing Rule 5620(a) following a deficiency notice for failing to hold an annual meeting within twelve months of its fiscal year end. The company also established an October 26, 2026 deadline for stockholder proposals to be included in the proxy materials.
BJ's Wholesale Club Holdings, Inc. filed an amendment to its 2026 Annual Meeting results to disclose the board's decision on the frequency of executive compensation votes. Following shareholder preference at the meeting, the company will hold advisory 'Say-on-Pay' votes on an annual basis.
Elastic N.V. held its 2026 Annual General Meeting where shareholders approved eleven proposals, including the appointment of three non-executive directors for three-year terms. Shareholders also adopted the Dutch statutory annual accounts for fiscal year 2026 and ratified PricewaterhouseCoopers as the company's independent auditor for fiscal year 2027.
Beam Global has scheduled its 2026 Annual Meeting of Stockholders for December 17, 2026, with a record date of October 19, 2026. The company also established October 26, 2026, as the new deadline for stockholder proposals and director nominations because the meeting date is more than 30 days after the anniversary of the prior year's meeting.